AQTIS Medical

Based in Netherlands, AQTIS Medical, which was recently acquired by Sinclair Pharma Ltd., specializes in the research, development, manufacture, and commercialization of medical devices for minimal invasive therapies in medical aesthetics and other selected therapeutic areas. The company has developed, Ellansé a biocompatible dermal filler that offers sustained performance, tunable longevity, and total bioresorbability (STAT Technology) that works by stimulating body’s own collagen and is fully resorbed by the body and includes a set of bioresorbable medical polymer and gel formulations for the field of aesthetic medicine and surgery.